TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis
Benjamin Loos(University of Zurich), Lukas Sommer(University of Zurich), Reinhard Dummer(University Hospital of Zurich), Phil F. Cheng(University Hospital of Zurich), Stefanie Rufli(University of Zurich), Adrián Salas-Bastos(University of Zurich), C. Wyss(University of Zurich), Claudio Cantù(Linköping University), Julien Debbache(University of Zurich), Salome Stierli(University of Zurich), Steve Pascolo(University of Zurich), Mitchell P. Levesque(University of Zurich), Anna Nordin(Linköping University), W. Wei‐Lynn Wong(University of Zurich)
Cited by 11
Related Papers
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
|Nature|2013|735
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
|Nature Communications|2015|332
Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth
|Cancer Research|2011|325
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
|Annals of Oncology|2020|232
Predictors of responses to immune checkpoint blockade in advanced melanoma
|Nature Communications|2017|201